Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "therapy"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
61
-
80
of
160
Search:
'"therapy"'
,
query time: 0.04s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
61
CADTH Canadian Drug Expert Committee recommendation: Edaravone (Radicava -- Mitsubishi Tanabe Pharma Corporation) : indication : for the treatment of amyotrophic lateral sclerosis
Published 2019
CADTH
Subjects:
“
...Amyotrophic Lateral Sclerosis / drug
therapy
...
”
Read Now
62
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Macular Edema / drug
therapy
...
”
Read Now
63
CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC) : indication : for the treatment of adult patients with cardiomyopathy due t...
Published 2020
CADTH
Subjects:
“
...Cardiomyopathies / drug
therapy
...
”
Read Now
64
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Familial Hypophosphatemic Rickets / drug
therapy
...
”
Read Now
65
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Muscular Atrophy, Spinal / drug
therapy
...
”
Read Now
66
CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) : indication: in adults, as an adjunct to standard of care therapy, for the...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... be reimbursed as an adjunct to standard of care
therapy
, for the treatment of HFrEF only if certain conditions...
”
Read Now
67
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthritis, Psoriatic / drug
therapy
...
”
Read Now
68
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthritis, Rheumatoid / drug
therapy
...
”
Read Now
69
CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Opioid-Related Disorders / drug
therapy
...
”
Read Now
70
CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Opioid-Related Disorders / drug
therapy
...
”
Read Now
71
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Subjects:
“
...Spinal Muscular Atrophies of Childhood / drug
therapy
...
”
Read Now
72
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...HIV Infections / drug
therapy
...
”
Read Now
73
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Diabetes Mellitus, Type 2 / drug
therapy
...
”
Read Now
74
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthritis, Psoriatic / drug
therapy
...
”
Read Now
75
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthritis, Rheumatoid / drug
therapy
...
”
Read Now
76
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Subjects:
“
...Spinal Muscular Atrophies of Childhood / drug
therapy
...
”
Read Now
77
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tyrosinemias / drug
therapy
...
”
Read Now
78
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tyrosinemias / drug
therapy
...
”
Read Now
79
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Pulmonary Disease, Chronic Obstructive / drug
therapy
...
”
Read Now
80
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Asthma / drug
therapy
...
”
1
2
3
4
5
6
7
8
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
153
330 - Economics
99
140 - Specific philosophical schools
15
700 - The arts; fine & decorative arts
14
580 - Plants (Botany)
1
Language
English
160
Collection
National Center for Biotechnology Information
160
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
124
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=4&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22therapy%22&type=AllFields
Send by Email
×
Loading...